Correspondence 0001493152-25-005207 from AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc.
Date: Feb. 6, 2025 · CIK: 0000946644 · Accession: 0001493152-25-005207
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284443
Letter
Re: AIM ImmunoTech Inc.
February 6, 2025
VIA EDGAR
Securities and Exchange Commission
F Street, NE
Washington, DC 20549
Registration Statement on Form S-1
(SEC filing No. 333-284443)
Acceleration Request
Requested Date: February 10, 2025
Requested Time: 2:00 P.M. Eastern Standard Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), AIM ImmunoTech Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-284443) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission (the Commission”).
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Silverman Shin & Schneider PLLC, by calling Richard Feiner, Esq. at (646) 822-1170. We also respectfully request that a copy of the written order from the Commission verifying the effective date and time of the Registration Statement be sent to Mr. Feiner via email at rfeiner@silverfirm.com.
Very
truly yours,
AIM
IMMUNOTECH INC.
Show Raw Text
CORRESP
1
filename1.htm
February
6, 2025
VIA
EDGAR
Securities
and Exchange Commission
100
F Street, NE
Washington,
DC 20549
Re:
AIM
ImmunoTech Inc.
Registration
Statement on Form S-1
(SEC
filing No. 333-284443)
Acceleration
Request
Requested
Date: February 10, 2025
Requested
Time: 2:00 P.M. Eastern Standard Time
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), AIM ImmunoTech Inc. (the “Company”)
hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-284443) (the “Registration Statement”)
be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the
Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and
Exchange Commission (the Commission”).
Once
the Registration Statement has been declared effective, please orally confirm that event with our counsel, Silverman Shin & Schneider
PLLC, by calling Richard Feiner, Esq. at (646) 822-1170. We also respectfully request that a copy of the written order from the Commission
verifying the effective date and time of the Registration Statement be sent to Mr. Feiner via email at rfeiner@silverfirm.com.
Very
truly yours,
AIM
IMMUNOTECH INC.
By:
/s/
Peter W. Rodino, III,
Peter
W. Rodino, III,
Chief
Operation Officer
cc:
Richard Feiner, Esq.
Corporate
Headquarters
2117
SW Highway 484, Ocala FL 34473
t: 352-448-7797
f: 352-480-4620
Human
Resources and Administration
604
Main Street, Riverton NJ 08077
t: 352-448-7797
f: 352-480-4620
Operations,
Research and Development
671A
US-1 South, North Brunswick, NJ 08902
www.aimimmuno.com
t: 732-249-3250
f: 732-249-6895